https://www.avient.com/sites/default/files/2022-07/REMAFIN EP White Masterbatches for Pharma Application Bulletin_CN.pdf
埃万特对本文件所含信息的准确性、在特定应用中的适用性、或利用这些信息获得或可获得的结果不做任何陈述、保证和担保。
加工条件可能会导致材料属性背离信息中所述的数值。
对于这些信息或信息中所提及的产品,埃万特不做出任何明示或暗示的保证,包 括但不限于对特定用途的适销性和合适性的暗示保证。
https://www.avient.com/knowledge-base/article/quality-design?ind[]=6598
This encompasses the principles of change control management, good manufacturing practices (GMP) and the ISO13485 quality standard, as well as regulatory support service.
Change control agreements with up to three years’ notification.
Fingerprinting and routine batch testing of the raw materials used in MEVOPUR and REMAFIN-EP help detect changes and implement countermeasures.
https://www.avient.com/knowledge-base/article/quality-design?rtype[]=1164
This encompasses the principles of change control management, good manufacturing practices (GMP) and the ISO13485 quality standard, as well as regulatory support service.
Change control agreements with up to three years’ notification.
Fingerprinting and routine batch testing of the raw materials used in MEVOPUR and REMAFIN-EP help detect changes and implement countermeasures.
https://www.avient.com/knowledge-base/article/bringing-global-vision-2020-s-usee-life?rtype[]=1164
Clear sight is truly a life-changing gift.”
I can’t thank Avient and its design team enough for donating their time, passion and expertise to help change the world with the gift of clear sight.”
With thousands of applicants from all over the world, the USee™ was again recognized as a game changing idea that will transform millions of lives.
https://www.avient.com/knowledge-base/article/bringing-global-vision-2020-s-usee-life?ind[]=6598
Clear sight is truly a life-changing gift.”
I can’t thank Avient and its design team enough for donating their time, passion and expertise to help change the world with the gift of clear sight.”
With thousands of applicants from all over the world, the USee™ was again recognized as a game changing idea that will transform millions of lives.
https://www.avient.com/knowledge-base/article/transform-product-development-fea?rtype[]=1164
Iterate rapidly to see how design changes affect performance
With a qualitative model, when the design is changed or refined, you can very quickly and easily get results through simulation for how the iteration might perform in reality.
What happens if you change the material, processing conditions, testing conditions, or environmental variables?
https://www.avient.com/knowledge-base/article/bringing-global-vision-2020-s-usee-life
Clear sight is truly a life-changing gift.”
I can’t thank Avient and its design team enough for donating their time, passion and expertise to help change the world with the gift of clear sight.”
With thousands of applicants from all over the world, the USee™ was again recognized as a game changing idea that will transform millions of lives.
https://www.avient.com/knowledge-base/article/quality-design
This encompasses the principles of change control management, good manufacturing practices (GMP) and the ISO13485 quality standard, as well as regulatory support service.
Change control agreements with up to three years’ notification.
Fingerprinting and routine batch testing of the raw materials used in MEVOPUR and REMAFIN-EP help detect changes and implement countermeasures.
https://www.avient.com/industries/transportation/advanced-mobility
Whether they’re adjusting the seat or changing the station, drivers want dependable, intuitive vehicle controls.
Meet the ever-changing demands of your electrical vehicles and systems with a new breed of composite materials engineered to fit your needs.
Whether they’re adjusting the seat or changing the station, drivers want dependable, intuitive vehicle controls.
https://www.avient.com/investor-center/news/avient-provides-third-quarter-2020-performance-update
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include the impact the COVID-19 pandemic has on our business, results from operations, financial condition and liquidity; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's Masterbatch business and achieve the expected results of the acquisition of Clariant's Masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.